article · The Egyptian Journal of Medical Microbiology
Background: Systemic lupus erythematosus is an autoimmune disease. Parvovirus B19 infection can break tolerance to self-DNA and promote pathogenesis of autoimmunity and might induce either idiopathic SLE in a person who is genetically susceptibl or it might induce a SLE-like picture. Objectives: Detection of PV-B19 DNA and it's IgM and IgG antibodies in the serum of SLE patients and in apparently healthy volunteer in Benha University Hospitals. Methodology: The study was conducted on 60 subjects classified into 2 groups: Group I: Including 40 SLE patients fulfilling SLICC Classification Criteria , 20 of them were in exacerbation state and the other 20 cases were in remission state and Group II: Including 20 age and sex matched apparently healthy volunteers serve as a control group . All patients were subjected to full history taking, clinical examination and laboratory investigations. PV- B19 IgM and IgG were measured using anti PV- B19 ELISA kits and PV-B19 DNA was detected by using real timepolymerase chain reaction(PCR). Results: PV- B19 DNA was detected in 9 cases (45%) with active disease, Out of the 9 patients with PV- B19 DNA, only 1 had positive PCR results alone , 1 had positive PCR and IgM results and 7 had positive PCR, IgM and IgG results. on the other hand, PV- B19 DNA was detected in only 1 case (5%) out of 20 remittent cases (p=0.003). Active cases were significantly associated with higher frequency of IgM and IgG when compared to remittent cases (p=0.010, 0.020, respectively).There was significant differences in SLEDAI between active and remitted cases (p < 0.001). Conclusion: Combined use of PCR and ELISA are needed for accurate diagnosis of PV- B19 infection.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/ejmm.2022.212000
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.